申请人:Genzyme Corporation
公开号:EP3078373A1
公开(公告)日:2016-10-12
A compound for use in treating polycystic kidney disease is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of treating polycystic kidney disease in a subject in need thereof comprises administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. Methods of treating in polycystic kidney disease in a subject in need thereof respectively comprise administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof.
一种用于治疗多囊肾病的化合物由结构式(I)代表:或其药学上可接受的盐。一种药物组合物包含由结构式(I)代表的化合物或其药学上可接受的盐。一种治疗有需要的受试者的多囊肾病的方法,包括向受试者施用治疗有效量的结构式(I)所代表的化合物或其药学上可接受的盐。分别治疗有需要的受试者的多囊肾病的方法包括向受试者施用治疗有效量的结构式(I)所代表的化合物或其药学上可接受的盐。